²é¿´: 987  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

qiandaofanying

½ð³æ (ÕýʽдÊÖ)

[½»Á÷] Ïò¹úÍâѧÊõÆÚ¿¯Í¶¸å×¢ÒâÊÂÏî

Ò»¡¢ ÕýÈ·Ñ¡ÔñÆÚ¿¯
       ¹úÍâÓ¢ÎÄÆÚ¿¯ÖÖÀà·±¶à£¬¼´Ê¹ÔÚͬһ·Ö֧ѧ¿Æ»òͬһרҵҲÓÐÐí¶àÆÚ¿¯£¬²¢ÇÒ¸÷¸öÆÚ¿¯µÄ°ì¿¯×ÚÖ¼¡¢×¨Òµ·¶Î§¡¢Ö÷Ìâ·ÖÅä¡¢À¸Ä¿ÉèÖü°¸÷ÖÖÀàÐÍÎÄÕ·¢±íµÄ±ÈÀý¾ù²»Ïàͬ¡£Òò´Ë£¬Ñ¡ÔñÒ»±¾Ç¡µ±µÄÆÚ¿¯²¢·ÇÒ»¼þÒ×Ê£¬³£³£Òª»¨·Ñ½Ï¶àµÄʱ¼ä£¬È»¶øÕâÊÇÂÛÎÄд×÷ǰ±Ø²»¿ÉÉÙµÄÖØÒªÒ»²½£¬ÊÇÂÛÎĵÃÒÔ·¢±íµÄÒ»¸ö¼«ÆäÖØÒªµÄ»·½Ú¡£
      Ñ¡ÔñÆÚ¿¯Ó¦¿¼ÂǵÄÒòËØ:
      1¡¢×÷ÕßÊ×ÏÈӦȷ¶¨×Ô¼ºµÄÂÛÎÄÖ÷ÌâÊÇ·ñÔÚ¿¯ÎïµÄÕ÷¸å·¶Î§ÄÚ¼°ÂÛÎÄ׫д¸ñʽÊÇ·ñÓ뿯ÎïµÄÒªÇóÒ»Ö£¬Èç¹û´ð°¸ÊÇ¡°·ñ¡±£¬ÔòÓ¦Á¢¼´Í£Ö¹¶Ô¸Ã¿¯ÎïµÄ½øÒ»²½¡°Ñо¿¡±£¬¶øÓ¦È¥Ñ°ÕÒÆäËü¿ÉÄܵĿ¯Îï¡£ÄâͶÂÛÎÄ¿ÉÄܼ«ÎªÓÅÐ㣬µ«Èç¹û²»ÊʺÏÓڸÿ¯ÎÔò²»¿ÉÄÜÔڸÿ¯Îï±»·¢±í¡£
      2¡¢ÆÚ¿¯µÄÉùÍû(prestige)
      ÆÚ¿¯µÄѧÊõˮƽ¸ß£¬ÆäÉùÍû¾Í¸ß£»·´Ö®£¬ÉùÍûÔòµÍ¡£¸÷¹úÉúÎïҽѧ¹¤×÷Õß¶¼Ï£Íû×Ô¼ºµÄ¿ÆÑгɹûÄܹ»·¢±íÔÚÓÐÉùÍûµÄ¸ßÖÊÁ¿µÄÉúÎïҽѧÆÚ¿¯ÉÏ¡£ÒòΪÉùÍû¸ßµÄÆÚ¿¯ÓÐÀûÓÚÐÅÏ¢µÄ¹ú¼Ê¼ä´«²¥ºÍ½»Á÷£¬²¢¶ÔѧÊõ³É¹ûµÄÈϿɾßÓÐȨÍþÐÔ¡£
      3¡¢Ñ¡ÔñÆÚ¿¯µÄ·½·¨
Èç¹ûÄâͶÂÛÎĵÄÖ÷ÌâÔÚÒ»¸öºÜÕ­µÄ·Ö֧ѧ¿ÆÄÚ£¬ÄÇô×÷ÕßµÄÑ¡Ôñ·¶Î§Ö»ÄÜÏÞÖÆÔÚ¼¸ÖÖ¿¯ÎïÖУ»Ïà·´£¬Èç¹ûÂÛÎĵÄÐÅÏ¢½»²æÁ˼¸¸öÑо¿ÁìÓò£¬Ôò×÷Õß¿ÉÒÔÓÐÐí¶àÖÖÑ¡Ôñ¡£È»¶øÎÞÂÛÊÇÄÄÖÖÇéÏÈÁгöÒ»¸ö¼òµ¥µÄÄâÑ¡ÆÚ¿¯±í£¬È»ºóÖðÒ»¶ÔÄâÑ¡ÆÚ¿¯½øÐбȽÏɸѡ£¬×÷³ö×îºó¾ñÔñ¡£
¶þ¡¢ÈÏÕæÔĶÁºÍʹÓÃͶ¸åÐëÖª
        1¡¢¶Á¿¯Í·(masthead statement£¬Í¨³£·ÅÔÚÆÚ¿¯Ç°ÃæµÄÎÄÌâÒ³ÉÏ)£¬ÒÔÁ˽⿯Ãû¡¢¼òµ¥µÄ°ì¿¯×ÚÖ¼¡¢±à¼­Î¯Ô±»á×é³É¡¢±à¼­²¿³ÉÔ±¡¢³ö°æÉ̼°ÆäÁªÏµµØÖ·µÈ¡£
        2¡¢ä¯ÀÀĿ¼(table of contents)£¬ÒÔÈ·¶¨¸Ã¿¯ÎïÊÇ·ñ·¢±íÄãÑо¿ÁìÓòµÄÎÄÕ¼°·¢±íµÄ±ÈÀýÓжà´ó¡£
        3¡¢×¢ÒâÀ¸Ä¿ÉèÖã¬È·¶¨ÄâͶ¸å¼þµÄÀ¸Ä¿¡£
        4¡¢¿´ÄâͶÀ¸Ä¿ÎÄÕµķ¶Àý£¬Á˽â׫дҪÇó¼°¸ñʽ¡£
        5¡¢Ä³Ð©ÆÚ¿¯¿¯µÇÎÄÕµÄͶ¸åºÍ½ÓÊÕÈÕÆÚ£¨submitted and accepted dates£©£¬×÷Õ߿ɾݴ˼ÆËã³öÂÛÎijö°æÊ±ÖÍ£¨·¢±íÖÜÆÚ£©¡£
        6¡¢×¢Òâ¹ã¸æÊýÁ¿£¬ÒÔ¼ä½ÓÅÐ¶ÏÆÚ¿¯ÖÊÁ¿¡£ÒòΪ¿¯µÇ¹ã¸æµÄ¹«Ë¾¶¼Ô¸Ò⽫½ðǮͶµ½ÖÊÁ¿¸ß¡¢Ó°Ïì´óµÄÆÚ¿¯ÉÏ¡£
        7¡¢Í¨¹ý11»ò12Ô·ݳö°æµÄÔÓÖ¾×îºó¼¸Ò³Éϵġ°ËùÓÐȨ¡¢¹ÜÀíºÍ·¢ÐÐÉùÃ÷¡±£¨statement of ownership£¬management£¬and circulation£©²éÕÒÆÚ¿¯·¢ÐÐÁ¿¡£
        8¡¢ºË²éÓÐÎÞ±±ÃÀºÍÅ·ÖÞÒÔÍâ¹ú¼Ò×÷Õß׫дµÄÎÄÕ¡£
        9¡¢ÓÐЩÆÚ¿¯»¹¿¯µÇ±¨µÀ¼Æ»®£¬×÷Õß¿ÉÒÀ´ËÄâ¶©×Ô¼ºµÄͶ¸å¼Æ»®¡£
Èý¡¢Í¶¸å×¢ÒâÊÂÏî
        µ±¾ö¶¨ÁËÂÛÎĵÄÖ÷Ì⣬ȷ¶¨ÁËÂÛÎĵĶÁÕßȺ£¬²¢Ñ¡¶¨ÁËÂÛÎÄÄâͶÆÚ¿¯ºó£¬ÂÛÎĵÄÎÄÏ×¼ìË÷¹¤×÷±ãÍê³ÉÁË¡£ÏÂÒ»²½¾ÍÊÇÈ·¶¨ÂÛÎÄ×÷Õß¡¢²é¿´ÆÚ¿¯µÄ¡°Í¶¸åÐëÖª¡±£¬²¢½«Ñо¿½á¹ûµÄԭʼ×ÊÁÏÊÕ¼¯ÔÚÒ»Æð¿ªÊ¼×«Ð´ÂÛÎÄ¡£ÂÛÎÄ׫дÊÇÒ»Ïî¼è¿àµÄ¹¤×÷£¬²¢·ÇÒ»¸å¾ÍÄÜÍê³É£¬ÍùÍùÐèÒª·´¸´Ò׸壨Ð޸쩲ÅÄÜʹÎÄÕ´ﵽͶ¸åµÄÒªÇ󣬼´Ëùν"5C"¡ªÕýÈ·£¨correctness£©¡¢Çå³þ£¨clarity£©¡¢¼ò½à£¨concision£©¡¢ÍêÕû£¨completion£©ºÍÒ»ÖÂÐÔ£¨consistency£©¡£
        ×«Ð´ÂÛÎijõ¸å£¨writing the first draft£©
        ÂÛÎĵÄ׫д²½Öè¼°¸÷²¿·ÖµÄÖ÷ÒªÌØµãÈçÏ£º
        1¡¢²ÄÁϺͷ½·¨£¨methods and materials£©£º×öÁËʲôºÍÔõÑù×ö£¿²ÄÁϺͷ½·¨ÊÇÎÄÕ¿ªÊ¼Ð´×÷µÄ×îÀíÏ벿·Ö£¬ÒòΪÕⲿ·ÖµÄÄÚÈÝ×÷Õß×îÁ˽⡣»ù±¾Ð´×÷ÒªÇó£ºÓùýȥʱ£¬¾¡¿ÉÄܰ´ÊµÑéÑо¿µÄÏȺó˳ÐòÃèÊö¡£
        2¡¢½á¹û£¨results£©£º·¢ÉúÁËʲô£¿»ù±¾Ð´×÷ÒªÇó£ºÊý¾Ý¿ÉÓÃͼ¡¢±í»òÎÄ×Ö±í´ï£¬µ«ÈýÕß¼äÓ¦¾¡ÉÙÖØ¸´ÔÚÕýÎIJ¿·ÖÐðÊöÖ÷Òª½á¹ûºÍÒâÒ壬ÓÃͼ»ò±í¸ø³ö½ÏÏêϸµÄÊý¾ÝÓùýȥʱ .
        3¡¢ÌÖÂÛ£¨discussion£©£ºËù»ñµÃµÄ½á¹ûÊÇ·ñΪ¡°Ç°ÑÔ¡±ÖÐÌᣮ³öµÄ¹Ø¼üÎÊÌâµÄ´ð°¸£¿½á¹ûÈçºÎÖ§³Ö´ð°¸£¿»ù±¾Ð´×÷ÒªÇ󣺼¯ÖÐÌÖÂÛÓë±¾½á¹ûÓйصÄÎÊÌ⣬ͻ³ö±¾Ñо¿µÄ´´Ð¼°ÖØÒªÐÔ£¬²¢ÓëÏà¹ØµÄÑо¿½á¹û½øÐбȽϸø³ö½á¹ûËùÖ§³ÖµÄ½áÂÛÓÃÏÖÔÚʱÐðÊöÒÑÖª»ò±»Ö¤Ã÷µÄÊÂʵ£¬ÓùýȥʱÃèÊö±¾Ñо¿½á¹û.
        4¡¢²Î¿¼ÎÄÏ×£¨references£©£ºÓë±¾Ñо¿·½·¨¡¢½á¹û¡¢ÌÖÂÛÓÐ¹ØµÄÆäËüÑо¿ÊÇʲô£¿ÆäÖøÂ¼ÒªÇóÊÇ£º×¼È·¡¢ÍêÕû¡¢¹æ·¶¡£
        5¡¢Ç°ÑÔ£¨introduction£©±¾Ñо¿µÄ±³¾°ºÍÄ¿µÄÊÇʲô£¿±¾Ñо¿ÊÔͼ»Ø´ðµÄ¹Ø¼ü¼äÌâÊÇʲô£¿»ù±¾Ð´×÷ÒªÇ󣺱¾Ñо¿Ä¿µÄ¼°ÖØÒªÐÔ£¬¼òÒª¸´Ï°ÎÄÏ× ¡£
        6¡¢ÖÂл£¨acknowledgment£©£º³ýÁË×÷Õߣ¬Ë­Ð­ÖúÍê³ÉÁ˱¾Ñо¿¡¢·ÖÎö½á¹û²¢×«Ð´ÂÛÎÄ£¿Ë­ÌṩÁË»ù½ðºÍÎïÖʵİïÖú£¿»ù±¾Ð´×÷ÒªÇ󣺽öÁгö¶Ô±¾¹¤×÷Ìá¹©ÌØÊâµÄʵÖÊÐÔ¹±Ï×ÕßµÄÐÕÃû±ØÐëµÃµ½±»ÖÂлÕßµÄͬÒâ ¡£
        7¡¢ÕªÒª£¨abstract£©£ºÂÛÎĸæËßÎÒÃÇʲô£¿£¨Í¨³£¡´250×Ö£©£¬ÕªÒªÊÇÂÛÎÄÒªµãµÄŨËõ£¬Òò´ËÓ¦ÔÚÎÄÕ¸÷Ö÷Òª²¿·ÖÍê³ÉºóÔÙд£¬ÕâÑùÓÐÀûÓÚÎÄÕÂÒªµãµÄÌáÁ¶¡£ÓÅÐãµÄÕªÒªÄÜÓÐЧµØ×¥×¡¶ÁÕßµÄÐËȤ¡£»ù±¾Ð´×÷ÒªÇó£ºÓú¬ÓбØÒª´Ê»ãµÄ¶ÌµÄ¼òµ¥¾ä£¬ÒÔʹժҪÇå³þ¶ø¼ò½à&S226;±ÜÃâʹÓÃËõд´ÊºÍ»ÞɬÄѶ®µÄ´Ê¾äÓÃС±êÌâÐðÊöÑо¿ÂÛÎĵĸ÷²¿·ÖÓùýȥʱ£¨µ«ÎÊÌâµÄ³ÂÊöºÍ½áÂÛ¿ÉÓÃÏÖÔÚʱ£©Ç¿µ÷Ñо¿µÄ´´ÐºÍÖØÒª·½Ãæ ¡£
        8¡¢ÎÄÌ⣨title£©£º±¾ÎĹØÓÚʲô£¿×î¼ÑÎÄÌâµÄ±ê×¼ÊÇÓÃ×îÉٵıØÒªÊõÓïȥ׼ȷÃèÊöÂÛÎĵÄÄÚÈÝ¡£»ù±¾Ð´×÷ÒªÇó£º×¼È·£¨accuracy£©¡¢¼ò½à£¨brevity£©ºÍÓÐЧ£¨effectiveness£©¡£
        9¡¢×÷Õߣ¨author list£©£ºË­²ÎÓëÁ˱¾Ñо¿µÄÉè¼Æ¡¢¹¤×÷¼°ÂÛÎĵÄ׫д£¿
        ×¼±¸ÂÛÎÄ×îºóÒ»¸å£¨preparing the final manuscript£©£º
        ÂÛÎijõ¸åÍê³ÉÒԺ󣬱ØÐë¶ÔÆäÄÚÈݼ°¸ñʽ½øÐз´¸´µÄÍÆÇúÍÐ޸ģ¬ÒÔ´ïµ½¡°Í¶¸åÐëÖª¡±ËùÌá³öµÄÒ»ÇÐÒªÇó¡£ÓÈÆäÊÇͶ¸øÆÚ¿¯µÄ¸å¼þÒ»¶¨Òª´ïµ½ÆÚ¿¯ËùÒªÇóµÄ±à¼­¸ñʽ£¬·ñÔò²»µ«²»Äܱ»½ÓÊÜ·¢±í£¬ÉõÖÁÓÚ¸ù±¾²»Ó迼ÂÇ¡£ÒòΪ¾ø´ó¶àÊýÓо­ÑéµÄ±à¼­¶¼ÈÏΪ£º²»ÈÏÕæ×¼±¸µÄ¸å¼þ¾ø²»ÊǸßˮƽ¿ÆÑ§Ñо¿³É¹ûµÄÁ¼ºÃÔØÌ壨A poorly prepared manuscript is£¬almost without fail£¬the carrier vehicle of poor science. Day AR.£©¡£ËùÒÔ£¬Èç¹ûÏ£ÍûÂÛÎı»·¢±í£¬ÔÚ×¼±¸Í¶¸øÆÚ¿¯µÄ¸å¼þʱ±ØÐë×öµ½´ò×ÖÕû½à¡¢ÎÞ´í¡¢·ûºÏÆÚ¿¯¸ñʽ¡¢º¬ÓÐÆÚ¿¯ÒªÇóµÄËùÓвÄÁÏ¡£
        ×¼±¸ÂÛÎÄ×îºóÒ»¸åÒ»°ã·ÖÈý²½£¬Ê×ÏÈÊÇÔÙ´ÎÔĶÁÄâͶÆÚ¿¯µÄ¡°Í¶¸åÐëÖª¡±£¬È»ºóÓá°Í¶¸åÐëÖª¡±ÖÐÌṩµÄ¡°¸å¼þ¶ÔÕÕ¼ì²é±í¡±(manuscript checklist, author's checklist)Óë×Ô¼ºµÄÂÛÎÄÒ»Ò»ºË¶Ô£¬×îºó¸ù¾ÝÆÚ¿¯ÒªÇó´ò×Ö£¬Íê³É×îºóÒ»¸å¡£
       Ͷ ¸å £º
        ÂÛÎĵÄ×îºóÒ»¸å°´¡°Í¶¸åÐëÖª¡±µÄÒªÇó×¼±¸ºÃÒԺ󣬾ͿÉÒÔÏò¹úÍâͶ¸åÁË¡£Ò»°ãÀ´Ëµ£¬Í¶¸å³ÌÐò·ÖÒÔÏÂÈý²½½øÐУº
        1¡¢×¼±¸Í¶¸åÐÅ£¨covering letter£¬submission letter£©
        ÆÚ¿¯µÄ±à¼­ÍùÍùÐèҪһЩÓйØ×÷ÕߺÍ×÷ÕßÂÛÎĵÄÐÅÏ¢£¬¶ø×÷ÕßҲϣÍû¸ø±à¼­ÌṩһЩÓÐÖúÓÚÆäÈ«ÎÄËÍÉó¼°¾ö²ßµÄÐÅÏ¢¡£ÕâЩÐÅÏ¢¶¼Ó¦¸Ã°üÀ¨ÔÚͶ¸åÐÅÖС£Í¶¸åÐÅÓ¦°üÀ¨ÒÔϼ¸·½ÃæµÄÄÚÈÝ£º
       ÎÄÌâºÍËùÓÐ×÷ÕßµÄÐÕÃû £»
        ¸å¼þÊÊÒ˵ÄÀ¸Ä¿ £»
         ÎªÊ²Ã´´ËÂÛÎÄÊʺÏÓÚÔڸÿ¯¶ø²»ÊÇÆäËü¿¯ÎïÉÏ·¢±í&S226;¹ØÓÚÖØ¸´»ò²¿·Ö·¢±í»òÒÑͶËü¿¯µÄ˵Ã÷ £»
        ²»ÄÜתÈðæÈ¨µÄ˵Ã÷£¨ÈçÃÀ¹úÁª°îÕþ¸®¹ÍÔ±£©£»
        ½¨ÒéÉó¸åÈ˼°Òò´æÔÚ¾ºÕù¹ØÏµ¶ø²»ÒË×öÉó¸åÈ˵ÄÃûµ¥ £»
        Í¨ÐÅ×÷Õߣ¨corresponding author£©µÄÐÕÃû¡¢ÏêϸµØÖ·¡¢µç»°ºÍ´«ÕæºÅÂë¡¢e-mailµØÖ· £»
        ÄÜ·ñ¸¶³ö°æ·Ñ£¨°æÃæ·Ñ¡¢²Êͼ·Ñ£©µÄ˵Ã÷£¨Èç¹û¸Ã¿¯ÊÕÈ¡°æÃæ·ÑºÍ²Êͼ·Ñ£©£»
        Ï£ÍûºËУУÑù»ò¸å¼þÈô²»½ÓÊÕÍË»ØÔ­¸åµÄÒªÇó£¨ÓÐµÄÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÔ¼¶¨£¬³ý·Ç×÷ÕßÔÚͶ¸åÐÅÖÐÌá³öÒªÇ󣬷ñÔòÔ­¸å²»ÍË»¹¸ø×÷Õߣ©¡£
        Í¶¸åОÙÀý£º
Dear Dr£®£º
Enclosed are three copies of a manuscript by Rose N £®Dipaola£¬Donna A£®Gallo£¬and Tom N£®Roberts titled¡°Hepatitis C Virus Infection in Long-Term Transfusion Patients¡±£®It is submitted to be considered for publication as a¡°Original Article" in your journal£®This paper is¡«&S226;Neither the entire paper nor any part of its content has been published or has been accepted elsewhere £®It is not being submitted to any other journal£®
We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general po***tion and of short-term transfusion patients£®
Correspondence and phone calls about the paper should be directed to Rose N£®Dipaola at the following address£¬phone and fax number£¬and e-mail address£º
Rose N £®Dipaola£¬MD
Institute of Internal Medicine
Cleveland Clinic Foundation
9500 Euclid Ave£®
Cleveland£¬OH44195£¬USA
Tel£º1-216-444-5360
Fax£º1-216-444-9580
E-mail£ºdipao£Àcesmtp £®ccf. Org
Thanks very much for your attention to our paper£®
Sincerely yours£¬
Rose N£®Dipaola
2¡¢¸å¼þ°ü×°
      Ëùν¸å¼þ°ü×°ÊÇÖ¸½«¸å¼þ¼°ÆäÄâͶÆÚ¿¯ËùÐèµÄ°éËæ×ÊÁÏÒ»²¢×°ÈËÐÅ·â¡£Ò»°ãÓ¦°´ÒÔÏÂ˳Ðò±¸Æë×ÊÁÏ£º
      Í¶¸åÐÅ£»
       ¿¯ÎïÒªÇóµÄ¸å¼þ£¨°üÀ¨ÎÄÌâÒ³¡¢ÎÄÕªÒ³¡¢ÕýÎÄ¡¢ÖÂл¡¢²Î¿¼ÎÄÏס¢Í¼×¢¡¢±í¼°Í¼£©¿½±´·ÝÊý£¬Ã¿·Ýͼµ¥¶À×°Ò»¸öÐŷ⣻
       °æÈ¨×ªÈÃÉùÃ÷ £»
        Óë¸å¼þÄÚÈÝÓйØ×ÊÁϵĿ½±´£¨ÈçѧÊõ»áÒ鱨¸æÂÛÎÄ»òÒÑ·¢±íµÄÕªÒªµÈ²ÄÁÏ£©£»
        Í¨Öª¸å¼þÊÕµ½µÄÃ÷ÐÅÆ¬»òÓÐ×÷ÕßµØÖ·²¢Ìù×ãÓÊ×ʵÄÐŷ⣨ÊÊÓÃÓÚ²»·¢ÊՏ廨ִµÄÆÚ¿¯£©£»
        ÖÂлºÍʹÓò¡ÈËÕÕÆ¬»òÒýÓÃ˽ÈËͨÐŵÄÊéÃæÍ¬Òâ²ÄÁϵĸ´Ó¡¼þ£»
        ÓÐЩÆÚ¿¯ÒªÇ󸽸å¼þ¶ÔÕÕ¼ì²é±í £»
        ÒÔÉϲÄÁϲ»ÒªÓö©Ê鶤¹Ì¶¨£¬ÒÔÃâ;ÖÐÒò¶©Êé¶¤ÒÆ¶¯¶øË𻵸å¼þ£»µ«¿ÉÒÔÓôóÐÍÇú±ðÕë¹Ì¶¨£¬ÕÕÆ¬¿ÉÒÔÔÚÐÅ·âÖмÐӲֽƬ±£»¤¡£
3¡¢¸å¼þÓʼÄ
       Óʼĸå¼þӦעÒ⣺
       Ó¦ÖÁÉÙ×ÔÁôÒ»·Ý´òÓ¡µ×¸å £»
       ÐÅ·âÒª×ã¹»´ó£¬²¢×ã¹»½áʵ £»
        ÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¡°Í¶¸åÐëÖª¡±Öг£ÓÐ˵Ã÷£¬¶àÒªÇóÖ±½Ó¼Ä¸øÖ÷±à£© £»
        ÕÕÆ¬²»¿É¹ý´ó£¬×î´ó²»³¬¹ý8.5Ó¢´çx11Ó¢´ç&S226;Ìù×ãÓÊÆ± £»
        º½¿ÕÓÊ¼Ä ¡£
        ÒÔ´òÓ¡¸å£¨hard copy£©Í¶¸å ¼¸ºõËùÓеÄÓ¢ÎÄÆÚ¿¯¾ù²»½ÓÊÜ´«Õæ(fax)Ͷ¸å£¬Ä³Ð©ÆÚ¿¯½öÔÊÐíһЩûÓÐͼ±íµÄ¶ÌÎÄ»ò¡°¸ø±à¼­µÄÐÅ¡±Í¨¹ýµç×ÓÓʼþ£¨e-mail£©Í¶¸å£¬³¤ÆªÂÛÖø¡¢Ñо¿±¨¸æµÈÎÄÕ¾ö¶¨¿¯Óú󷽽ÓÊÜÈí´ÅÅÌ¡£ÒÔÉÏÐÅÏ¢¿ÉÒÔ´Ó¡°Í¶¸åÐëÖª¡±ÖлñµÃ¡¢ÓÐµÄÆÚ¿¯ÔÚ¡°Í¶¸åÐëÖª¡±ÖÐÌØ±ðÖ¸³öͶ¸åµØÖ·Óë¶©¿¯»ò¶©µ¥Ðб¾µÄµØÖ·²»Ò»Ñù£¬×÷ÕßÓ¦ÌØ±ð×¢Ò⣬ÒÔÃâÔì³É²»±ØÒªµÄʱ¼äµ¢¸é ¡£
       Ͷ¸åºóÈô¸ÉÊÂÒË £º
       ¸å¼þ×·×Ù(follow-up correspondence)£®
        Èç¹ûͶ¸å2ÖÜÈÔÎÞÈκÎÓйظå¼þÊÕµ½µÄÐÅÏ¢£¬Ò²¿É´òµç»°¡¢·¢e£­mail»òдПø±à¼­²¿ºËʵ¸å¼þÊÇ·ñÊÕµ½¡£
       ¸å¼þÍËÐÞ(revised manuscript) £º
        ¼¸ºõËùÓеľ­Éó²éѧÊõˮƽ´ïµ½³ö°æÒªÇóµÄ×ÔÓÉÀ´¸å£¬ÔÚ·¢±íǰ¶¼ÐèÒªÍ˸ø×÷ÕßÐÞ¸ÄÆä±íÊö¼°±à¼­¸ñʽ£¬ÈçѹËõÎÄÕÂÆª·ù¡¢ÖØÐÂÉè¼Æ±í¸ñ¡¢¸ÄÉÆ²åͼÖÊÁ¿¡¢ÏÞÖÆ²»¹æÔòËõд´ÊʹÓõȡ£È»¶øÍ˸ø×÷ÕßÐ޸ĵĸå¼þ²¢²»´ú±íÎÄÕÂÒѾ­±»½ÓÊÜ£¬ÎÄÕÂ×îÖÕ½ÓÊÜÓë·ñÈ¡¾öÓÚ×÷Õß¶ÔÎÄÕ¹ؼüÐÔÖØÒªÄÚÈݺͱíÊö·½Ê½µÄÐÞ¸ÄÄÜ·ñ´ïµ½Éó¸åר¼Ò¼°±à¼­µÄÒªÇó¡£
        Í¨³£Í˸ø×÷ÕßÐ޸ĵIJÄÁϰüÀ¨Ô­¸å¡¢Éó¸åר¼ÒÒâ¼û¡¢£¨reviewers' comments£©ºÍÒ»·â±à¼­µÄÐÅ£¨covering letter£©¡£µ±×÷ÕßÊÕµ¹ÍËÐÞ¸åºó£¬Ê×ÏÈÓ¦¸Ã×ÐϸµØÔĶÁÍËÐÞÐÅ£¨modify letter£©ºÍÉó¸åר¼ÒÒâ¼û¡£È»ºóÓ¦¿¼ÂÇÄÜ·ñ»òÔ¸Òâ½ÓÊÜÉó¸åר¼Ò»ò±à¼­µÄÒâ¼û£¬Ð޸ĸå¼þ¡£
Dear Prof. XXXXX,
Here within enclosed is our paper for consideration to be published on "(Journal name)". The further nformation about the paper is in the following:
The Title: XXXXXXXX
The Authors: XXX XXX and XXX
The authors claim that none of the material in the paper has been published or is under consideration for publication elsewhere.
I am the corresponding author and my address and other information is asfollows,
Address: Department of XXXX,
Tsinghua University,
Beijing, 10084,
P.R.China
E-mail: [email=[ft=#323456,,]XXX@mail.tsinghua.edu.cn]XXX@mail.tsinghua.edu.cn[/email]
Tel: 86-10-XXXXXXX
Fax: 86-10-XXXXXXX
Thank you very much for consideration!
Sincerely Yours,
Dr. XXX
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

Ͷ¹úÍâÆÚ¿¯×¢ÒâÊÂÏî

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tower598

Ìú¸Ëľ³æ (Ö°Òµ×÷¼Ò)

ÉÏÍø´ïÈË

ºÜºÃ£¬Ñ§Ï°
2Â¥2009-10-23 23:16:44
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wuzezhou

ľ³æ (ÖªÃû×÷¼Ò)

¶àл£¬Ì«ºÃÁË£¡£¡£¡
¶¼27ÁË¡£´Ëʱ²»Æ´£¬¸ü´ýºÎʱ£¡
3Â¥2009-10-23 23:25:54
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

visitor958

ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)

IEEEÔÓÖ¾Óë»áÒéר¼Ò

ÄĸöÄê´úµÄ£¿

---------------
3¡¢¸å¼þÓʼÄ
       Óʼĸå¼þӦעÒ⣺
       Ó¦ÖÁÉÙ×ÔÁôÒ»·Ý´òÓ¡µ×¸å £»
       ÐÅ·âÒª×ã¹»´ó£¬²¢×ã¹»½áʵ £»
        ÕýÈ·µÄͶ¸åµØÖ·¼°ÊÕ¸åÈË£¨¡°Í¶¸åÐëÖª¡±Öг£ÓÐ˵Ã÷£¬¶àÒªÇóÖ±½Ó¼Ä¸øÖ÷±à£© £»
        ÕÕÆ¬²»¿É¹ý´ó£¬×î´ó²»³¬¹ý8.5Ó¢´çx11Ó¢´ç&S226;Ìù×ãÓÊÆ± £»
        º½¿ÕÓÊ¼Ä ¡£

[ Last edited by visitor958 on 2009-10-23 at 23:29 ]
4Â¥2009-10-23 23:28:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ qiandaofanying µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çó²ÄÁϵ÷¼Á +8 ¸ô±Ú³ÂÏÈÉú 2026-03-12 8/400 2026-03-18 22:19 by li123456789.
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á +4 Ymlll 2026-03-18 6/300 2026-03-18 22:15 by li123456789.
[¿¼ÑÐ] 271²ÄÁϹ¤³ÌÇóµ÷¼Á +4 .6lL 2026-03-18 4/200 2026-03-18 20:05 by ˜B¸ç
[¿¼ÑÐ] 331Çóµ÷¼Á£¨0703Óлú»¯Ñ§ +7 ZY-05 2026-03-13 8/400 2026-03-18 14:13 by 007_lilei
[¿¼ÑÐ] 302Çóµ÷¼Á +10 ºôºôºô¡£¡£¡£¡£ 2026-03-17 10/500 2026-03-18 12:45 by Linda Hu
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á +4 pupcoco 2026-03-17 7/350 2026-03-18 12:14 by djl2006
[¿¼ÑÐ] 0854£¬¼ÆËã»úÀàÕÐÊÕµ÷¼Á +3 ºúÀ±ÌÀ·ÅÌÇ 2026-03-15 6/300 2026-03-18 12:09 by Éϰ¶Éϰ¶¡­¡­..
[¿¼ÑÐ] 303Çóµ÷¼Á +4 î£08 2026-03-17 6/300 2026-03-18 11:01 by Iveryant
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 085601Çóµ÷¼Á +4 Du.11 2026-03-16 4/200 2026-03-17 17:08 by ruiyingmiao
[¿¼ÑÐ] 332Çóµ÷¼Á +6 Zz°æ 2026-03-13 6/300 2026-03-17 17:03 by ruiyingmiao
[¿¼ÑÐ] 285»¯¹¤Ñ§Ë¶Çóµ÷¼Á£¨081700£© +9 ²ñ¿¤Ã¨_ 2026-03-12 9/450 2026-03-17 10:18 by Sammy2
[¿¼ÑÐ] 11408 Ò»Ö¾Ô¸Î÷µç£¬277·ÖÇóµ÷¼Á +3 zhouzhen654 2026-03-16 3/150 2026-03-17 07:03 by laoshidan
[¿¼ÑÐ] 318Çóµ÷¼Á +3 Yanyali 2026-03-15 3/150 2026-03-16 16:41 by houyaoxu
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶Çóµ÷¼Á +6 Ì«Ïë½ø²½ÁË0608 2026-03-16 6/300 2026-03-16 16:13 by kykm678
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼ÁÒ»Ö¾Ô¸ 985 ×Ü·Ö 295 +8 dream¡­¡­ 2026-03-12 8/400 2026-03-13 22:17 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 311Çóµ÷¼Á +3 ¶¬Ê®Èý 2026-03-13 3/150 2026-03-13 20:41 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏר˶350 Çóµ÷¼Á +4 Íõ½ð¿Æ 2026-03-12 4/200 2026-03-13 16:02 by ruiyingmiao
[¿¼²©] ¸£ÖÝ´óѧÑî»ÆºÆ¿ÎÌâ×éÕÐÊÕ2026Äêרҵѧλ²©Ê¿Ñо¿Éú£¬2026.03.20½ØÖ¹ +3 Xiangyu_ou 2026-03-12 3/150 2026-03-13 09:36 by duanwu655
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û